House Committee Targets FDA's 'Untitled Letter' Discipline

The oversight panel of the House Energy & Commerce Committee is questioning the U.S. Food and Drug Administration's use of so-called untitled letters to discipline drugmakers over shoddy advertising and manufacturing,...

Already a subscriber? Click here to view full article